文献速递肺栓塞与肺血管病

肺动脉高压中的交感兴奋:肺动脉压力感受器的潜在作用

Sympatho-Excitation in Pulmonary Hypertension: The Potential Role of Pulmonary Arterial Baroreceptors: An Acute Physiologic Intervention Study.
PubMed 文献 · Respirology · 2026-02-03

该急性生理干预研究纳入11例临床稳定的肺动脉高压患者(9例PAH,2例CTEPH),通过腓总神经微神经造影记录肌肉交感神经活动(MSNA),观察雾化伊洛前列素对MSNA的影响。伊洛前列素降低收缩期肺动脉压并增加右室流出道加速时间,但MSNA总体无变化;MSNA爆发大小的变化与RVOT AT增加呈负相关。提示肺动脉压力感受器可能影响部分患者的MSNA爆发幅度。

要点

  • 雾化伊洛前列素降低收缩期肺动脉压并增加RVOT加速时间。
  • MSNA总体无显著变化,但MSNA爆发大小变化与RVOT AT增加负相关。
  • 肺动脉压力感受器可能参与肺动脉高压的交感兴奋机制。

核心结论

  • 研究提示肺动脉压力感受器可能影响部分肺动脉高压患者的MSNA爆发幅度。
  • 肺动脉压力感受器激活可能是肺动脉高压交感兴奋的机制之一。

研究设计与样本

  • 急性生理干预研究,纳入11例临床稳定的肺动脉高压患者(9例PAH,2例CTEPH;6例女性;年龄54±14岁)。
  • 采用腓总神经微神经造影记录MSNA(n=9),基线10分钟及雾化伊洛前列素后10分钟测量。
  • 同步评估心肺生理及经胸超声心动图肺动脉血流动力学。

主要发现

  • 雾化伊洛前列素降低收缩期肺动脉压(50±19 mmHg基线 vs. 44±15 mmHg伊洛前列素;p=0.040)。
  • 伊洛前列素增加右室流出道加速时间(99±15 ms基线 vs. 117±16 ms伊洛前列素;p<0.001)。
  • MSNA总体无显著变化(p>0.05)。
  • MSNA爆发大小变化与RVOT AT增加呈负相关(R2=0.667,p=0.0133)。

临床怎么用

  • 对于临床稳定的PAH和CTEPH患者,雾化伊洛前列素可急性降低收缩期肺动脉压并改善右室流出道加速时间。
  • MSNA爆发大小变化与RVOT AT增加负相关,提示肺动脉压力感受器可能参与交感兴奋调节,但需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Sympathetic nerve activity is heightened in pulmonary arterial hypertension (PAH), promotes deleterious pulmonary vascular and right ventricular remodelling, and is associated with worsened exercise capacity and mortality. Pulmonary arterial baroreceptors, activated by increased pulmonary arterial pressure and distension, could drive muscle sympathetic nerve activity (MSNA) in pulmonary hypertension (PH). We hypothesised that pulmonary arterial baroreceptor unloading using nebulised iloprost as a pulmonary arterial vasodilator would lower MSNA in clinically stable treated PAH and chronic thromboembolic PH (CTEPH) patients. METHODS: In eleven PH patients (9 PAH, 2 CTEPH; 6 female; age 54 ± 14 years) common peroneal nerve microneurography was performed to record MSNA (n = 9) at baseline (10 min) and immediately following iloprost nebulisation (10 min). Concurrent measures of cardiorespiratory physiology and pulmonary haemodynamics (transthoracic echocardiography) were obtained. RESULTS: Iloprost reduced systolic pulmonary artery pressure (50 ± 19 mmHg baseline vs. 44 ± 15 mmHg iloprost; p = 0.040), and increased right ventricular outflow tract acceleration time (RVOT AT; 99 ± 15 ms baseline vs. 117 ± 16 ms iloprost; p < 0.001). Although no overall change was seen in MSNA (p > 0.05), the magnitude of change in MSNA burst size was inversely associated with the increase in RVOT AT (R2 = 0.667, p = 0.0133). CONCLUSION: These findings provide evidence suggestive of possible pulmonary arterial baroreceptor influence of MSNA burst amplitude in some PH patients. Pulmonary arterial baroreceptor activation may be a contributory mechanism to adverse sympatho-excitation in PH. CLINICAL TRIAL REGISTRATION: ACTRN12622000494730.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Plunkett MJ, Sayegh ALC, Lewis RA, et al. Sympatho-Excitation in Pulmonary Hypertension: The Potential Role of Pulmonary Arterial Baroreceptors: An Acute Physiologic Intervention Study. Respirology. 2026. PMID: 41631458. doi:10.1002/resp.70207

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。